ResMed Inc. (RMD) Social Stream
RESMED INC (RMD) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering RMD.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-01 | 12 | $312 | $227 | $261.5 | $173 | 51.16% |
| 2021-12-21 | 11 | $312 | $227 | $264.875 | $173 | 53.11% |
| 2022-01-13 | 11 | $312 | $234 | $273.25 | $173 | 57.95% |
| 2022-01-18 | 11 | $312 | $234 | $272.125 | $173 | 57.3% |
| 2022-01-24 | 11 | $312 | $234 | $273.5 | $173 | 58.09% |
| 2022-01-25 | 11 | $312 | $234 | $274.75 | $173 | 58.82% |
| 2022-01-28 | 11 | $312 | $235 | $272.125 | $173 | 57.3% |
| 2022-03-24 | 11 | $312 | $235 | $272.75 | $173 | 57.66% |
| 2022-04-06 | 11 | $312 | $235 | $273.555 | $173 | 58.12% |
| 2022-04-26 | 11 | $312 | $235 | $273 | $173 | 57.8% |
| 2022-05-01 | 11 | $312 | $201 | $264.666 | $173 | 52.99% |
| 2022-05-02 | 11 | $300 | $201 | $257.777 | $173 | 49% |
| 2022-05-27 | 12 | $300 | $201 | $257.777 | $173 | 49% |
| 2022-06-06 | 12 | $300 | $201 | $259.777 | $173 | 50.16% |
| 2022-06-14 | 12 | $300 | $201 | $258.111 | $173 | 49.2% |
| 2022-06-16 | 12 | $300 | $201 | $254.875 | $173 | 47.33% |
| 2022-07-24 | 11 | $300 | $204 | $259 | $173 | 49.71% |
| 2022-08-12 | 11 | $300 | $204 | $259 | $173 | 49.71% |
| 2022-08-13 | 11 | $300 | $222 | $263.125 | $173 | 52.1% |
| 2022-08-16 | 11 | $300 | $222 | $262.5 | $173 | 51.73% |
| 2022-10-05 | 11 | $300 | $222 | $262.5 | $173 | 51.73% |
| 2022-10-12 | 12 | $300 | $222 | $260.555 | $173 | 50.61% |
| 2022-10-26 | 12 | $300 | $222 | $262.222 | $173 | 51.57% |
| 2022-10-28 | 12 | $300 | $222 | $262.222 | $173 | 51.57% |
| 2022-12-01 | 12 | $300 | $211 | $261.111 | $173 | 50.93% |
| 2022-12-13 | 11 | $300 | $211 | $261.111 | $173 | 50.93% |
| 2023-01-12 | 10 | $280 | $211 | $256.25 | $173 | 48.12% |
| 2023-01-27 | 9 | $280 | $219 | $256.857 | $173 | 48.47% |
| 2023-04-18 | 10 | $280 | $219 | $256.875 | $173 | 48.48% |
| 2023-04-28 | 10 | $280 | $219 | $257.062 | $173 | 48.59% |
| 2023-05-03 | 10 | $280 | $229 | $258.125 | $173 | 49.21% |
| 2023-05-22 | 11 | $290 | $229 | $261.666 | $173 | 51.25% |
| 2023-08-04 | 11 | $290 | $207 | $254.555 | $173 | 47.14% |
| 2023-08-07 | 11 | $290 | $207 | $257.888 | $173 | 49.07% |
| 2023-08-14 | 11 | $290 | $207 | $251.111 | $173 | 45.15% |
| 2023-09-06 | 12 | $275 | $170 | $234.777 | $173 | 35.71% |
| 2023-09-13 | 11 | $275 | $170 | $217.555 | $173 | 25.75% |
| 2023-09-18 | 11 | $275 | $170 | $215.333 | $173 | 24.47% |
| 2023-10-05 | 12 | $275 | $165 | $207 | $173 | 19.65% |
| 2023-10-12 | 12 | $275 | $165 | $199.111 | $173 | 15.09% |
| 2023-10-16 | 12 | $220 | $165 | $186.888 | $173 | 8.03% |
| 2023-10-20 | 12 | $220 | $165 | $182.444 | $173 | 5.46% |
| 2023-10-27 | 12 | $220 | $165 | $182.444 | $173 | 5.46% |
| 2023-10-29 | 12 | $220 | $158 | $180.444 | $173 | 4.3% |
| 2023-10-30 | 12 | $220 | $158 | $178.222 | $173 | 3.02% |
| 2023-10-31 | 12 | $220 | $158 | $177.111 | $173 | 2.38% |
| 2023-12-07 | 13 | $220 | $155 | $176.777 | $173 | 2.18% |
| 2023-12-21 | 13 | $220 | $155 | $179 | $173 | 3.47% |
The Trend in the Analyst Price Target
Over the past 30 months, RMD's average price target has gone down $49.33.
Over the past 49 weeks, RMD's average upside potential has been 26.89%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-27 | 8 | 280 | 219 | 256.857 | 224.59 | 14.37% |
| 2023-05-03 | 10 | 280 | 229 | 258.125 | 236.80 | 9.01% |
| 2023-07-05 | 11 | 290 | 221 | 260.777 | 216.44 | 20.48% |
| 2023-07-17 | 11 | 290 | 221 | 260.777 | 220.77 | 18.12% |
| 2023-09-06 | 12 | 275 | 170 | 234.777 | 153.33 | 53.12% |
RMD Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.73 | 7 | 2 | 4 | 0 | 0 | 13 |
The Trend in the Broker Recommendations
Over the past 19 months, RMD's average broker recommendation rating worsened by 0.1.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- RESMED INC's average analyst price target is greater than 5786.67% of all US stocks.
- In terms of how RESMED INC fares relative to stocks in the large market cap category, note that its upside potential (average analyst target price relative to current price) is greater than 4701.54% of that group.
- RMD has a lower variance in analysts' estimates than -1560.38% of Healthcare stocks.
- RMD has a higher number of analysts covering the stock than 4446.75% of Healthcare stocks.
Stocks similar to RESMED INC in the Medical Equipment industry regarding analyst recommendations and price targets are TFX, XRAY, and ALC.
View All Top Stocks by Price Target
Make investment decisions regarding RMD using the data that counts. Try POWR Ratings for free.